首页> 外国专利> PRESENTED IN Salmonella enterica N-GLYCAN FROM C.jejuni AND ITS DERIVATIVES

PRESENTED IN Salmonella enterica N-GLYCAN FROM C.jejuni AND ITS DERIVATIVES

机译:以空肠沙门氏菌及其衍生物肠沙门氏菌N-聚糖为载体。

摘要

1. Salmonella enterica, characterized in that it contains at least one pgl operon from Campylobacter jejuni or a functional derivative thereof and presents at least one Campylobacter jejuni N-glycan or derivative of such N-glycan on its cell surface. 2. Salmonella enterica according to claim 1, selected from the group consisting of Salmonella typhimurium, enteriditis, heidelberg, gallinorum, hadar, agona, kentucky and infantis, more preferably from strains of Salmonella enterica serovar Typhimurium. Salmonella enterica according to any one of claims 1 or 2, containing at least one pgl operon, in which one or more genes for bacillosamine biosynthesis are inactivated by a mutation and / or partial or complete deletion, preferably a partial and / or complete deletion of pgl D genes , E, F, G. 4. Salmonella enterica according to any one of claims 1 or 2, containing at least one pgl operon in which the pglB gene product is inactivated by mutation and / or deletion. Salmonella enterica according to any one of claims 1 or 2, in which at least one N-glycan has the formula (I) GalNAc-a1,4-GalNAc-a1,4- [Glc-β-1,3] GalNAc- a1,4-Gal-NAc-a1,4-GalNAc-a1,3-Bac, where you (also called bacillosamine) is 2,4-diacetamido-2,4,6-tridesoxy-D-glucopyranose. 6. Salmonella enterica according to any one of claims 1 or 2, in which at least one N-glycan derivative has the formula (II) GalNAc-a1,4-GalNAc-a1,4- [Glc-β-1,3] GalNAc -a1,4-Gal-NAc-a1,4-GalNAc-a1,3-GlcNAc. 7. Salmonella enterica according to any one of claims 1 or 2, in which the N-glycan (s) or derivative (s) is associated with at least one homologous or heterologous Salmonella polypeptide that is carried and presented on the cell surface, and preferably associated with at least one polypeptide containing at least one HZS / T consensus sequence, more preferably D / EXNZS / T (SEQ ID NO: 1), where X and Z can be any naturally occurring amino acid
机译:1.肠炎沙门氏菌,其特征在于它含有至少一种来自空肠弯曲杆菌的pgl操纵子或其功能衍生物,并在其细胞表面上存在至少一种空肠弯曲杆菌N-聚糖或这种N-聚糖的衍生物。 2.根据权利要求1的肠沙门氏菌,选自鼠伤寒沙门氏菌,肠炎,海德堡,鸡胆,哈达雷,阿肯色,肯塔基州和婴儿,更优选地选自肠炎沙门氏菌鼠伤寒沙门氏菌。 3.根据权利要求1或2中任一项所述的肠炎沙门氏菌,其包含至少一个pgl操纵子,其中用于细菌素生物合成的一个或多个基因通过突变和/或部分或完全缺失,优选地部分和/或完全缺失而失活。 4.根据权利要求1或2中任一项的肠沙门氏菌,其包含至少一个pgl操纵子,其中所述pglB基因产物通过突变和/或缺失而失活。 3.根据权利要求1或2中任一项的肠沙门氏菌,其中至少一种N-聚糖具有式(I)GalNAc-a1,4-GalNAc-a1,4- [Glc-β-1,3] GalNAc-a1 ,4-Gal-NAc-a1,4-GalNAc-a1,3-Bac,其中您(也称为杆菌胺)是2,4-二乙酰氨基-2,4,6-三脱氧-D-吡喃葡萄糖。 6.根据权利要求1或2中任一项的肠沙门氏菌,其中至少一种N-聚糖衍生物具有式(II)GalNAc-a1,4-GalNAc-a1,4- [Glc-β-1,3] GalNAc -a1,4-Gal-NAc-a1,4-GalNAc-a1,3-GlcNAc。 7.根据权利要求1或2中任一项的肠沙门氏菌,其中所述N-聚糖或衍生物与至少一种携带或呈递在细胞表面上的同源或异源沙门氏菌多肽缔合,和优选与至少一种含有至少一个HZS / T共有序列的多肽相关,更优选与D / EXNZS / T(SEQ ID NO:1)相关,其中X和Z可以是任何天然氨基酸

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号